Letter: higher severe outcomes among <i>Helicobacter pylori</i>‐related lean patients with non‐alcoholic fatty liver disease and metabolic comorbidities-Reference-Cited by-同舟云学术

Letter: higher severe outcomes among Helicobacter pylori‐related lean patients with non‐alcoholic fatty liver disease and metabolic comorbidities

Published:2023-04-24 Issue:10 Volume:57 Page:1186-1187
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kountouras Jannis¹^ORCID,Papaefthymiou Apostolis¹²³^ORCID,Polyzos Stergios A.³^ORCID,Kazakos Evangelos¹⁴,Tzilves Dimitrios⁵,Touloumtzi Maria¹,Chatzopoulos Dimitrios¹,Tzitiridou‐Chatzopoulou Maria¹⁴,Liatsos Christos⁶,Zavos Christos¹,Kavaliotis John¹,Kulaksiz Hasan⁷,Doulberis Michael¹³⁷⁸^ORCID

Affiliation:

1. Department of Medicine Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital Thessaloniki Macedonia Greece

2. Pancreaticobiliary Medicine Unit University College London Hospitals (UCLH) London UK

3. First Laboratory of Pharmacology School of Medicine, Aristotle University of Thessaloniki Thessaloniki Macedonia Greece

4. Midwifery Department School of Healthcare Sciences, University of West Macedonia Kozani Macedonia Greece

5. Gastroenterology Department Theageneio Hospital Thessaloniki Macedonia Greece

6. Department of Gastroenterology General Military Hospital of Athens Attiki Greece

7. Gastroklinik, Private Gastroenterological Practice Horgen Switzerland

8. Department of Gastroenterology and Hepatology University of Zurich Zurich Switzerland

Abstract

LINKED CONTENTThis article is linked to Wijarnpreecha et al paper. To view this article, visit https://doi.org/10.1111/apt.17424.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17484

Reference10 articles.

1. Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities

2. Letter: Helicobacter pylori in lean and obese patients with non-alcoholic fatty liver disease

3. A potential impact of Helicobacter pylori ‐related sarcopenia on severity of portal hypertension

4. A perspective on risk factors for esophageal adenocarcinoma: emphasis onHelicobacter pyloriinfection

5. Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients